Hospital Drug and Therapeutics Committees in Australia: is there a role for economic evaluation at the institutional level?

Abstract

Decisions about spending on medicines occur at different levels in the Australian health care system. This commentary describes the role of economic evaluation at the institutional (public hospital) level. In contrast to the decisions taken at the level of Federal subsidy (listing on the Pharmaceutical Benefits Scheme) formal pharmacoeonomic data analyses… (More)
DOI: 10.1007/s11096-011-9565-3

Topics

  • Presentations referencing similar topics